Malignancies following long-term azathioprine treatment in chronic liver disease |
| |
Authors: | U. Tage-Jensen,P. Schlichting,H. F. Thomsen,G. H ybye,Aa. C. Thomsen |
| |
Affiliation: | U. Tage-Jensen,P. Schlichting,H. F. Thomsen,G. Høybye,Aa. C. Thomsen, |
| |
Abstract: | ABSTRACT— One hundred and fifty-four patients with histologically verified nonalcoholic chronic liver disease were randomized to azathioprine or prednisone treatment. After a median of 91 months observation time, the cause of death was assessed retrospectively. Autopsy was performed in 82% of 71 deaths. In the azathioprine group 33% (13/39) died from malignant neoplasia, and in the prednisone group (13%) (4/32) (p = 0.08). Considering a possible fatal outcome as a consequence of treatment, this finding urges caution in the long-term application of azathioprine at the usual dose level. |
| |
Keywords: | azathioprine chronic liver disease malignant neoplasia |
|
|